APA

Kovalchin J., King B., Masci A., Hopkins E., Fry J., Hou J., Li C., Tenneson K., Weber S., Wolfe G., Collins K. & Furfine E. S. (20180514). Preclinical Development of EBI-005: An IL-1 Receptor-1 Inhibitor for the Topical Ocular Treatment of Ocular Surface Inflammatory Diseases. : Eye & contact lens.

Chicago

Kovalchin Joseph, King Bracken, Masci Allyson, Hopkins Elizabeth, Fry Jeremy, Hou Jay, Li Christian, Tenneson Kelly, Weber Steve, Wolfe Gary, Collins Kathy and Furfine Eric S. 20180514. Preclinical Development of EBI-005: An IL-1 Receptor-1 Inhibitor for the Topical Ocular Treatment of Ocular Surface Inflammatory Diseases. : Eye & contact lens.

Harvard

Kovalchin J., King B., Masci A., Hopkins E., Fry J., Hou J., Li C., Tenneson K., Weber S., Wolfe G., Collins K. and Furfine E. S. (20180514). Preclinical Development of EBI-005: An IL-1 Receptor-1 Inhibitor for the Topical Ocular Treatment of Ocular Surface Inflammatory Diseases. : Eye & contact lens.

MLA

Kovalchin Joseph, King Bracken, Masci Allyson, Hopkins Elizabeth, Fry Jeremy, Hou Jay, Li Christian, Tenneson Kelly, Weber Steve, Wolfe Gary, Collins Kathy and Furfine Eric S. Preclinical Development of EBI-005: An IL-1 Receptor-1 Inhibitor for the Topical Ocular Treatment of Ocular Surface Inflammatory Diseases. : Eye & contact lens. 20180514.